Clinical Trial Update: Comparison of Efficacy and Safety of Prandilin and NovoRapid in Newly Diagnosed Type 2 Diabetes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing the efficacy and safety of Prandilin versus NovoRapid in newly diagnosed Type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• NovoRapid (insulin aspart)
• Prandilin (insulin lispro)

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED